AG0038EG

85622-93-1 | 3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide

AG0038EG

SDS

COA

Price

$0.00

WARNING This product is not for human or veterinary use.

CAS Number	85622-93-1
Catalog Number	AG0038EG(AGN-PC-0JK78E)
Chemical Name	3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide
IUPAC Name	3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
InChI	InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)
InChI Key	BPEGJWRSRHCHSN-UHFFFAOYSA-N
MDL Number	MFCD00866492
Molecular Formula	C6H6N6O2
Molecular Weight	194.1508
SMILES	CN1N=NC=2N(C1=O)C=NC2C(=O)N
UNII	YF1K15M17Y
Synonyms	8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one, CCRG 81045, CCRG-81045, CCRG81045, M and B 39831, M and B-39831, M and B39831, methazolastone, NSC 362856, NSC-362856, NSC362856, Temodal, Temodar, temozolomide, temozolomide hexyl ester, TMZ Bioshuttle, TMZ-Bioshuttle, TMZA-HE, temozolomide, 85622-93-1, Methazolastone, Temodal, Temodar, Temozolamide, 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, Temozolomidum, Temozolomidum [Latin], Temozolodida [Spanish], Temozolodida, CCRG 81045, CCRG-81045, Sch 52365, NSC 362856, Sch-52365, M&B-39831, CCRIS 8996, MB 39831, M&B 39831, UNII-YF1K15M17Y, M & B 39831, NSC-362856, BRN 5547136, 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one, NSC362856, CHEMBL810, M-39831, 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide, 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, MLS002701861, C6H6N6O2, YF1K15M17Y, CHEBI:72564, 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide, 3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide, Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-, MFCD00866492, NCGC00167429-01, 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide, DSSTox_CID_23714, DSSTox_RID_80068, DSSTox_GSID_43714, 3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, Temozolomide [INN:BAN], 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, 8-CARBAMOYL-3-METHYLIMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE, Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-, SMR000466338, Temodal (TN), Temodar (TN), CAS-85622-93-1, Temozolomide, VETRANAL(TM), analytical standard, SR-01000759347, temozolomida, Temozolomid, Temozolomide (JAN/USAN/INN), Temozolomide [USAN:INN:BAN], CCRG81045, zlchem 2, PubChem17413, Temodar (TN) (Schering), AC1L1K9B, SCHEMBL3739, MLS000759447, MLS001424028, BIDD:GT0204, GTPL7301, DTXSID5043714, CTK8B3724, KS-00000XGV, AOB1657, Temozolomide, >=98% (HPLC), ZLA0002, BPEGJWRSRHCHSN-UHFFFAOYSA-N, HMS2051O12, HMS2090B08, HMS2232N13, HMS3264I14, HMS3269P05, HMS3372K13, HMS3393O12, HMS3654N05, HMS3677D06, HMS3713H16, Pharmakon1600-01502289, ALBB-021358, BCP03692, ZINC1482184, Tox21_112433, AC-758, ANW-43023, BDBM50034562, CT0139, DL-190, NSC759883, s1237, STK623541, 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide, AKOS005557098, Tox21_112433_1, AN-5907, CCG-100870, CS-0943, DB00853, KS-1216, MCULE-9414994158, NC00120, NSC-759883, NCGC00167429-02, NCGC00167429-04, NCGC00167429-05, 4CA-1225, AJ-26318, AK-72945, BC206085, BR-72945, CJ-23657, CPD000466338, HY-17364, LS-80558, NCI60_003316, SAM001246636, SC-17333, BCP0726000154, AB0007590, TL8005593, AM20110227, FT-0630936, SW197500-4, D06067, M-2350, AB00639915-06, AB00639915-08, AB00639915-09, AB00639915_10, AB00639915_11, 199366-EP2275425A1, 622T931, A841386, I06-0149, I14-1943, Q-201786, SR-01000759347-4, SR-01000759347-5, BRD-K32107296-001-04-5, Z1551429743, 3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide, 3-methyl-8-carbamoyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, Temozolomide, United States Pharmacopeia (USP) Reference Standard, 3-methyl-4-oxidanylidene-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, 3-METHYL-4-OXO-8-IMIDAZOLO[5,1-D][1,2,3,5]TETRAZINECARBOXAMIDE, 3-Methyl-8-aminocarbonyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, Imidazo[5,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-, {Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,} 3, 4-dihydro-3-methyl-4-oxo-, 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide, 3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide, Temozolomide, Pharmaceutical Secondary Standard; Certified Reference Material, 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide (Temozolomide), 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide(Temozolomide), temomedac, TMZ-Bioshuttle, TMZ Bioshuttle, Temozolomide Teva, Temozolomide Hexal, Temozolomide Sandoz, Temozolomide Hospira, TMZA-HE, Temozolomide Hexyl Ester, Temozolomide [BAN:INN], D0C8EU, Essex brand of temozolomide, Scheringbrand of temozolomide, Temozolomide, 98% - 1G 1g, CID5394, C6-H6-N6-O2, Schering-Plough brand of temozolomide, ACN-028895, CS-O-02446, H027, M&B39831, M B 39831, B1399, T2744, A10575, C047246, D000077204, TMZ, 3,4-dihydro-3-methyl-4-oxo-imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,

Complexity	315
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	194.055g/mol
Formal Charge	0
Heavy Atom Count	14
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	194.154g/mol
Monoisotopic Mass	194.055g/mol
Rotatable Bond Count	1
Topological Polar Surface Area	106A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	-1.1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335-H340-H350-H360
Packing Group
Precautionary statements	P201-P261-P305+P351+P338-P308+P313-P280-P301+P312+P330
Signal Words	danger
UN Code

Certificate of Analysis

Lot Number